Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma-Reference-Cited by-同舟云学术

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Published:2023-08 Issue: Volume:189 Page:112900
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kennedy Oliver John,Kicinski Michal,Valpione Sara,Gandini Sara^ORCID,Suciu Stefan,Blank Christian U.,Long Georgina V.,Atkinson Victoria G.,Dalle Stéphane,Haydon Andrew M.,Meshcheryakov Andrey,Khattak Adnan,Carlino Matteo S.,Sandhu Shahneen,Larkin James,Puig Susana,Ascierto Paolo A.,Rutkowski Piotr^ORCID,Schadendorf Dirk^ORCID,Boers-Sonderen Marye,Di Giacomo Anna Maria,van den Eertwegh Alfonsus J.M.,Grob Jean-Jacques^ORCID,Gutzmer Ralf^ORCID,Jamal Rahima,van Akkooi Alexander C.J.,Robert Caroline,Eggermont Alexander M.M.,Lorigan Paul^ORCID,Mandala Mario^ORCID

Funder

Merck

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Ferlay J. Colombet M. Soerjomataram I. et al. Global and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018. International Agency for Research on Cancer/World Health Organization, Lyon; 2018 〈https://gco.iarc.fr〉.

2. International trends in the incidence of malignant melanoma 1953-2008—are recent generations at higher or lower risk?;Erdmann;Int J cancer,2013

3. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018

4. Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: updated results from the EORTC 1325-MG/KEYNOTE-054 trial;Eggermont;J Clin Oncol,2020

5. The mechanisms of action of metformin;Rena;Diabetologia,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma;Oral Diseases;2024-07-22

2. The role of immunotherapy in the treatment of skin melanoma: a contemporary perspective;Research and Practical Medicine Journal;2024-05-24

3. Impact of metformin on melanoma: a meta-analysis and systematic review;Frontiers in Oncology;2024-05-23

4. Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios;Expert Review of Molecular Diagnostics;2024-05-03

5. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation;Anticancer Research;2024-04-27